Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test.

<h4>Background</h4>The National Lung Screening Trial showed that CT screening for lung cancer led to a 20% reduction in mortality. However, CT screening has a number of disadvantages including low specificity. A validated autoantibody assay is available commercially (EarlyCDT®-Lung) to a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Isabel K Macdonald, Andrea Murray, Graham F Healey, Celine B Parsy-Kowalska, Jared Allen, Jane McElveen, Chris Robertson, Herbert F Sewell, Caroline J Chapman, John F R Robertson
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2012
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/8438960788f54e9abee9c438965f1446
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!